116 related articles for article (PubMed ID: 30746695)
1. Cross-sectional human immunodeficiency virus incidence estimation accounting for heterogeneity across communities.
Xu Y; Laeyendecker O; Wang R
Biometrics; 2019 Sep; 75(3):1017-1028. PubMed ID: 30746695
[TBL] [Abstract][Full Text] [Related]
2. Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial.
Laeyendecker O; Kulich M; Donnell D; Komárek A; Omelka M; Mullis CE; Szekeres G; Piwowar-Manning E; Fiamma A; Gray RH; Lutalo T; Morrison CS; Salata RA; Chipato T; Celum C; Kahle EM; Taha TE; Kumwenda NI; Karim QA; Naranbhai V; Lingappa JR; Sweat MD; Coates T; Eshleman SH
PLoS One; 2013; 8(11):e78818. PubMed ID: 24236054
[TBL] [Abstract][Full Text] [Related]
3. Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043).
Laeyendecker O; Piwowar-Manning E; Fiamma A; Kulich M; Donnell D; Bassuk D; Mullis CE; Chin C; Swanson P; Hackett J; Clarke W; Marzinke M; Szekeres G; Gray G; Richter L; Alexandre MW; Chariyalertsak S; Chingono A; Celentano DD; Morin SF; Sweat M; Coates T; Eshleman SH
PLoS One; 2013; 8(7):e68349. PubMed ID: 23874597
[TBL] [Abstract][Full Text] [Related]
4. A community trial of the impact of improved sexually transmitted disease treatment on the HIV epidemic in rural Tanzania: 1. Design.
Hayes R; Mosha F; Nicoll A; Grosskurth H; Newell J; Todd J; Killewo J; Rugemalila J; Mabey D
AIDS; 1995 Aug; 9(8):919-26. PubMed ID: 7576328
[TBL] [Abstract][Full Text] [Related]
5. Cross-sectional HIV incidence estimation in HIV prevention research.
Brookmeyer R; Laeyendecker O; Donnell D; Eshleman SH
J Acquir Immune Defic Syndr; 2013 Jul; 63 Suppl 2(0 2):S233-9. PubMed ID: 23764641
[TBL] [Abstract][Full Text] [Related]
6. Efficient estimation of human immunodeficiency virus incidence rate using a pooled cross-sectional cohort study design.
Molebatsi K; Gabaitiri L; Mokgatlhe L; Moyo S; Gaseitsiwe S; Wirth KE; DeGruttola V; Tchetgen Tchetgen E
Stat Med; 2020 Oct; 39(24):3255-3271. PubMed ID: 32875624
[TBL] [Abstract][Full Text] [Related]
7. Direct and indirect estimates of HIV-1 incidence in a high-prevalence population.
Cleghorn FR; Jack N; Murphy JR; Edwards J; Mahabir B; Paul R; O'Brien T; Greenberg M; Weinhold K; Bartholomew C; Brookmeyer R; Blattner WA
Am J Epidemiol; 1998 May; 147(9):834-9. PubMed ID: 9583713
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Overlap of Phylogenetic Transmission Clusters and Communities in Simple Sexual Contact Networks: Applications to HIV-1.
Villandre L; Stephens DA; Labbe A; Günthard HF; Kouyos R; Stadler T;
PLoS One; 2016; 11(2):e0148459. PubMed ID: 26863322
[TBL] [Abstract][Full Text] [Related]
9. Sample size methods for estimating HIV incidence from cross-sectional surveys.
Konikoff J; Brookmeyer R
Biometrics; 2015 Dec; 71(4):1121-9. PubMed ID: 26302040
[TBL] [Abstract][Full Text] [Related]
10. Testing the hypothesis that treatment can eliminate HIV: a nationwide, population-based study of the Danish HIV epidemic in men who have sex with men.
Okano JT; Robbins D; Palk L; Gerstoft J; Obel N; Blower S
Lancet Infect Dis; 2016 Jul; 16(7):789-796. PubMed ID: 27174504
[TBL] [Abstract][Full Text] [Related]
11. Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests.
Brookmeyer R; Quinn TC
Am J Epidemiol; 1995 Jan; 141(2):166-72. PubMed ID: 7817972
[TBL] [Abstract][Full Text] [Related]
12. Estimation of HIV incidence using multiple biomarkers.
Brookmeyer R; Konikoff J; Laeyendecker O; Eshleman SH
Am J Epidemiol; 2013 Feb; 177(3):264-72. PubMed ID: 23302151
[TBL] [Abstract][Full Text] [Related]
13. Rapid and simple screening and supplemental testing for HIV-1 and HIV-2 infections in west Africa.
Brattegaard K; Kouadio J; Adom ML; Doorly R; George JR; De Cock KM
AIDS; 1993 Jun; 7(6):883-5. PubMed ID: 8395857
[TBL] [Abstract][Full Text] [Related]
14. HIV-related stigma and universal testing and treatment for HIV prevention and care: design of an implementation science evaluation nested in the HPTN 071 (PopART) cluster-randomized trial in Zambia and South Africa.
Hargreaves JR; Stangl A; Bond V; Hoddinott G; Krishnaratne S; Mathema H; Moyo M; Viljoen L; Brady L; Sievwright K; Horn L; Sabapathy K; Ayles H; Beyers N; Bock P; Fidler S; Griffith S; Seeley J; Hayes R;
Health Policy Plan; 2016 Dec; 31(10):1342-1354. PubMed ID: 27375126
[TBL] [Abstract][Full Text] [Related]
15. Statistical power and estimation of incidence rate ratios obtained from BED incidence testing for evaluating HIV interventions among young people.
Auvert B; Mahiane GS; Lissouba P; Moreau T
PLoS One; 2011; 6(8):e21149. PubMed ID: 21853019
[TBL] [Abstract][Full Text] [Related]
16. Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.
Kirkpatrick AR; Patel EU; Celum CL; Moore RD; Blankson JN; Mehta SH; Kirk GD; Margolick JB; Quinn TC; Eshleman SH; Laeyendecker O
AIDS Res Hum Retroviruses; 2016 Aug; 32(8):756-62. PubMed ID: 26988426
[TBL] [Abstract][Full Text] [Related]
17. Stochastic variation in network epidemic models: implications for the design of community level HIV prevention trials.
Boren D; Sullivan PS; Beyrer C; Baral SD; Bekker LG; Brookmeyer R
Stat Med; 2014 Sep; 33(22):3894-904. PubMed ID: 24737621
[TBL] [Abstract][Full Text] [Related]
18. A community trial of the impact of improved sexually transmitted disease treatment on the HIV epidemic in rural Tanzania: 2. Baseline survey results.
Grosskurth H; Mosha F; Todd J; Senkoro K; Newell J; Klokke A; Changalucha J; West B; Mayaud P; Gavyole A
AIDS; 1995 Aug; 9(8):927-34. PubMed ID: 7576329
[TBL] [Abstract][Full Text] [Related]
19. Trends of HIV-1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi.
Taha TE; Dallabetta GA; Hoover DR; Chiphangwi JD; Mtimavalye LA; Liomba GN; Kumwenda NI; Miotti PG
AIDS; 1998 Jan; 12(2):197-203. PubMed ID: 9468369
[TBL] [Abstract][Full Text] [Related]
20. "The difference that makes a difference": highlighting the role of variable contexts within an HIV Prevention Community Randomised Trial (HPTN 071/PopART) in 21 study communities in Zambia and South Africa.
Bond V; Chiti B; Hoddinott G; Reynolds L; Schaap A; Simuyaba M; Ndubani R; Viljoen L; Simwinga M; Fidler S; Hayes R; Ayles H; Seeley J;
AIDS Care; 2016; 28 Suppl 3():99-107. PubMed ID: 27421057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
